郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro.

期刊:British journal of pharmacology发表年份:2012作者:L S Whyte; L Ford; S A Ridge; G A Cameron; M J Rogers; R A Ross

药效评价The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55.

期刊:Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology发表年份:2012作者:Haleli Sharir; Linda Console-Bram; Christina Mundy; Steven N Popoff; Ankur Kapur; Mary E Abood

药效评价Cannabinoid CB(2) receptor attenuates morphine-induced inflammatory responses in activated microglial cells.

期刊:British journal of pharmacology发表年份:2012作者:Stefania Merighi; Stefania Gessi; Katia Varani; Debora Fazzi; Prisco Mirandola; Pier Andrea Borea

药效评价Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1.

期刊:Journal of medicinal chemistry发表年份:2012作者:Fazel Shabanpoor; Mohammad Akhter Hossain; Philip J Ryan; Alessia Belgi; Sharon Layfield; Martina Kocan; Suode Zhang; Chrishan S Samuel; Andrew L Gundlach; Ross A D Bathgate; Frances Separovic; John D Wade